Background
Acute myeloid leukemia (AML) is a cancer of the myeloid line of blood cells, characterized by the rapid growth of abnormal cells that build up in the bone marrow and blood and interfere with normal blood cell production. AML cell lines are used in research to study the biology of AML and to develop new treatments. Some commonly used AML cell lines:
- HL-60: A human promyelocytic leukemia cell line.
- KASUMI-1: A cell line with a t(8;21) translocation.
- THP-1: A human monocytic leukemia cell line.
- OCI-AML3: A cell line with an inv(16) mutation.
- MV4-11: A human myelomonocytic leukemia cell line.
These cell lines are valuable for understanding the molecular mechanisms of AML and for testing potential therapeutic agents.
Fusion BioLabs provides validated DNA aptamer against those acute myeloid leukemia cancer cells.
Product Specification
Aptamer type: DNA aptamer
Aptamer length: 59 bp
Affinity KD: 101 nM by Cell-SELEX
Storage: keep at -20°C. DNA aptamers are guaranteed stable for 12 months when properly stored.